Provention Bio Valuation

Provention Bio Investor Information

About 53.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.52. Provention Bio had not issued any dividends in recent years. Based on the analysis of Provention Bio's profitability, liquidity, and operating efficiency, Provention Bio is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.

Provention Bio Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Provention Bio has an asset utilization ratio of 5.44 percent. This suggests that the Company is making $0.0544 for each dollar of assets. An increasing asset utilization means that Provention Bio is more efficient with each dollar of assets it utilizes for everyday operations.

Provention Bio Ownership Allocation

Provention Bio owns a total of 91.1 Million outstanding shares. Over half of Provention Bio's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Provention Bio Profitability Analysis

The company reported the previous year's revenue of 12.89 M. Net Loss for the year was (113.56 M) with loss before overhead, payroll, taxes, and interest of (63.42 M).

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

If you are still planning to invest in Provention Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Provention Bio's history and understand the potential risks before investing.